| Year |
Citation |
Score |
| 2022 |
Lashuel HA, Mahul-Mellier AL, Novello S, Hegde RN, Jasiqi Y, Altay MF, Donzelli S, DeGuire SM, Burai R, Magalhães P, Chiki A, Ricci J, Boussouf M, Sadek A, Stoops E, et al. Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. Npj Parkinson's Disease. 8: 136. PMID 36266318 DOI: 10.1038/s41531-022-00388-7 |
0.504 |
|
| 2022 |
Teixidor J, Novello S, Ortiz D, Menin L, Lashuel HA, Bertsch A, Renaud P. On-Demand Nanoliter Sampling Probe for the Collection of Brain Fluid. Analytical Chemistry. PMID 35786947 DOI: 10.1021/acs.analchem.2c01577 |
0.433 |
|
| 2022 |
Domenicale C, Mercatelli D, Albanese F, Novello S, Vincenzi F, Varani K, Morari M. Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines. 10. PMID 35453631 DOI: 10.3390/biomedicines10040881 |
0.619 |
|
| 2022 |
Novello S, Mercatelli D, Albanese F, Domenicale C, Brugnoli A, D'Aversa E, Vantaggiato S, Dovero S, Murtaj V, Presotto L, Borgatti M, Shimshek DR, Bezard E, Moresco RM, Belloli S, et al. In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162: 105579. PMID 34871735 DOI: 10.1016/j.nbd.2021.105579 |
0.697 |
|
| 2021 |
Sarti AC, Vultaggio-Poma V, Falzoni S, Missiroli S, Giuliani AL, Boldrini P, Bonora M, Faita F, Di Lascio N, Kusmic C, Solini A, Novello S, Morari M, Rossato M, Wieckowski MR, et al. Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance. Function (Oxford, England). 2: zqab005. PMID 35330818 DOI: 10.1093/function/zqab005 |
0.424 |
|
| 2021 |
Lashuel HA, Novello S. Lewy body-associated proteins: Victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein. Neurobiology of Disease. 105417. PMID 34102275 DOI: 10.1016/j.nbd.2021.105417 |
0.54 |
|
| 2021 |
Regoni M, Zanetti L, Comai S, Mercatelli D, Novello S, Albanese F, Croci L, Consalez GG, Ciammola A, Valtorta F, Morari M, Sassone J. Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse Biomedicines. PMID 34063112 DOI: 10.3390/biomedicines9050514 |
0.386 |
|
| 2021 |
Regoni M, Zanetti L, Comai S, Mercatelli D, Novello S, Albanese F, Croci L, Consalez GG, Ciammola A, Valtorta F, Morari M, Sassone J. Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9. PMID 34063112 DOI: 10.3390/biomedicines9050514 |
0.574 |
|
| 2020 |
Regoni M, Cattaneo S, Mercatelli D, Novello S, Passoni A, Bagnati R, Davoli E, Croci L, Consalez GG, Albanese F, Zanetti L, Passafaro M, Serratto GM, Di Fonzo A, Valtorta F, et al. Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death & Disease. 11: 963. PMID 33173027 DOI: 10.1038/s41419-020-03172-8 |
0.547 |
|
| 2020 |
Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P, Bohic S, Sandt C, Laferrière F, Doudnikoff E, Kruse N, ... ... Novello S, et al. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science Advances. 6: eaaz9165. PMID 32426502 DOI: 10.1126/Sciadv.Aaz9165 |
0.654 |
|
| 2020 |
Pisanò CA, Brugnoli A, Novello S, Caccia C, Keywood C, Melloni E, Vailati S, Padoani G, Morari M. Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease. Neuropharmacology. 167: 108006. PMID 32086070 DOI: 10.1016/J.Neuropharm.2020.108006 |
0.486 |
|
| 2019 |
Albanese F, Novello S, Morari M. Autophagy and LRRK2 in the Aging Brain. Frontiers in Neuroscience. 13: 1352. PMID 31920513 DOI: 10.3389/Fnins.2019.01352 |
0.579 |
|
| 2019 |
Mercatelli D, Pisanò CA, Novello S, Morari M. NOP Receptor Ligands and Parkinson's Disease. Handbook of Experimental Pharmacology. PMID 30689087 DOI: 10.1007/164_2018_199 |
0.547 |
|
| 2018 |
Gardoni F, Morari M, Kulisevsky J, Brugnoli A, Novello S, Pisano CA, Caccia C, Mellone M, Melloni E, Padoani G, Sosti V, Vailati S, Keywood C. Safinamide modulates striatal glutamatergic signalling in a rat model of levodopa-induced dyskinesia. The Journal of Pharmacology and Experimental Therapeutics. PMID 30291173 DOI: 10.1124/jpet.118.251645 |
0.517 |
|
| 2018 |
Novello S, Arcuri L, Dovero S, Dutheil N, Shimshek DR, Bezard E, Morari M. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice. Neurobiology of Disease. PMID 30172844 DOI: 10.1016/J.Nbd.2018.08.018 |
0.729 |
|
| 2018 |
Novello S, Arcuri L, Dovero S, Dutheil N, Shimshek DR, Bezard E, Morari M. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice Neurobiology of Disease. PMID 30172844 DOI: 10.1016/j.nbd.2018.08.018 |
0.526 |
|
| 2018 |
Tozzi A, Durante V, Bastioli G, Mazzocchetti P, Novello S, Mechelli A, Morari M, Costa C, Mancini A, Di Filippo M, Calabresi P. Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease. Neurobiology of Disease. PMID 29908325 DOI: 10.1016/J.Nbd.2018.06.008 |
0.61 |
|
| 2017 |
Arcuri L, Novello S, Frassineti M, Mercatelli D, Pisanò CA, Morella I, Fasano S, Journigan BV, Meyer ME, Polgar WE, Brambilla R, Zaveri NT, Morari M. Antiparkinsonian and antidyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. British Journal of Pharmacology. PMID 29232769 DOI: 10.1111/Bph.14123 |
0.456 |
|
| 2017 |
Morari M, Brugnoli A, Pisano CA, Novello S, Caccia C, Melloni E, Padoani G, Vailati S, Sardina M. Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia. The Journal of Pharmacology and Experimental Therapeutics. PMID 29167350 DOI: 10.1124/Jpet.117.245100 |
0.475 |
|
| 2017 |
Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, Russo I, Berti G, Mabrouk OS, Kennedy RT, Shimshek DR, Varani K, Bubacco L, Greggio E, Morari M. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta Neuropathologica Communications. 5: 22. PMID 28292328 DOI: 10.1186/S40478-017-0426-8 |
0.699 |
|
| 2017 |
Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, Russo I, Berti G, Mabrouk OS, Kennedy RT, Shimshek DR, Varani K, Bubacco L, Greggio E, Morari M. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice Acta Neuropathologica Commiunications. PMID 28292328 DOI: 10.1186/s40478-017-0426-8 |
0.466 |
|
| Show low-probability matches. |